CALL FOR APPLICATIONS FOR THE NATA 2025-2028 BOARD OF DIRECTORS

NATA is seeking dedicated leaders to help guide the Society into the future.

The NATA Board of Directors comprises a diverse group of professionals from different medical background, united by a shared commitment to ensuring that NATA remains internationally recognized as the leading society in Patient Blood Management (PBM), Haemostasis, and Thrombosis. The Board is responsible for upholding high standards in education, collaboration, and professional development for NATA members and the broader community.

The 2025-2028 Board of Directors will be presided over by incoming Chair Prof. Sigismond Lasocki. The Scientific Committee for this term will be chaired by Prof. Patrick Meybohm, and the Treasurer will be elected by the new Board of Directors. Together, these three roles form the NATA Executive Committee.

The term of office for Board Directors is staggered over several years to ensure continuity and stability in NATA’s governance.

Members whose term of office ends in April 2025 may reapply for a second term.

Elections for the Chair of NATA and Chair of the NATA Scientific Committee took place in April 2024. The past Chair of NATA automatically extends their term by one year on the Board of Directors to ensure continuity. 

Why serve?

The NATA Board of Directors is seeking up to six new candidates to serve a three-year term from May 2025 to April 2028. This is a valuable opportunity to contribute to the Society’s strategic direction, influence the future of NATA’s educational content and networking initiatives, and develop leadership skills while serving the PBM, Haemostasis, and Thrombosis community.

The Board of Directors holds full management and administrative authority over NATA. Director roles are voluntary and unpaid. New directors will be elected by the current Board of Directors. Additionally, all Board members automatically become Members of the NATA Scientific Committee.

Board Composition and Selection Criteria

The NATA Board of Directors is committed to achieving a balanced representation of gender and nationality. However, selection will primarily be based on expertise, experience, and potential contributions to the Society. While diversity is an important consideration, the Board’s primary objective is to appoint the most qualified individuals who can support NATA’s mission and drive its continued growth and impact.

Selection Process

The Executive Committee will conduct candidate meetings at NATA25 in Munich on 24 or 25 April 2025.

The Board of Directors will then select individuals who possess the strongest qualifications, experience, and ability to meaningfully contribute to NATA’s mission and objectives.

Eligibility and Application Requirements

Candidate Criteria

  • To be eligible, candidates must:
  • Be NATA Members in good standing.
  • Have a proven track record in their field.
  • Have published in PBM, Haemostasis, or Thrombosis.
  • Preferably, have experience in officer positions within other international, European, or national PBM, Haemostasis, or Thrombosis societies or relevant societies
  • Have an excellent professional network within the PBM, Haemostasis, and Thrombosis community.

 

Term of Office

May 2025 – April 2028, or until the conclusion of the 2028 NATA Annual Symposium.

Responsibilities and Commitment

Board members are expected to actively contribute to NATA’s development and operations, including but not limited to:

  • Identifying topics for NATA monthly webinars.
  • Organising and recruiting webinar speakers, as well as contributing as speakers and/or chairs.
  • Contributing to the Annual Symposium programme
  • Networking on behalf of NATA.
  • Promoting NATA and its activities.
  • Engaging with the PBM, Haemostasis, and Thrombosis community.
  • Fostering relationships with other organisations and stakeholders to expand NATA’s influence.

 

Commitments

  • Candidates must be willing to:
  • Serve the full three-year term.
  • Attend all Board of Directors meetings (held four times per year, including three virtual meetings and one in-person meeting the day before the Annual Symposium).
  • Attend the entire Annual NATA Symposium (a lump sum contribution will be provided towards travel and accommodation).

 

Application Process

Candidates must submit the following:

  • A short CV 
  • A brief written statement (max. 500 words) outlining their motivation, and experience volunteering for other scientific societies.
  • A list of publications.
  • A list of conflicts of interest.
 

Candidates must be nominated by a NATA Member in good standing and be prepared to attend a short interview with the current Executive Committee at the Annual Symposium in Munich on 24 or 25 April 2025.

Application deadline

20 April 2025, 23:59 CET

We look forward to welcoming passionate and dedicated individuals to help shape the future of NATA!

Current Board Of Directors

 

   

Term

  

Jens Meier

Austria

Chair

2022-2025

  

Sigismond Lasocki

France

Chair Scientific Committee

2022-2025

  

Patrick Meybohm

Germany

Treasurer

2022-2025

  
      

Elvira Bisbe

Spain

Member

2022-2025

  

Aurora Espinosa

Norway

Member

2023-2026

  

Vernon Louw

South Africa

Member

2023-2026

  

Toby Richards

UK 

Member

2022-2025

  

Marie Beatrice Rondinelli

Italy

Member

2022-2025

  

Ravishankar Rao Baikady

UK

Member 

2023-2026

  

 

April 2025 to April 2026 Board Of Directors

 

     

Sigismond Lasocki

France

Chair

2025-2028

 

Patrick Meybohm

Germany

Chair Scientific Committee

2025-2028

 

Vacant

 

Treasurer

2025-2028

 
     

Aurora Espinosa

Norway

Member

2026

Term ends in April 2026

Vernon Louw

South Africa

Member

2026

Term ends in April 2026

Jens Meier 

Austria

Past President 

2026

Term ends in April 2026

Ravishankar Rao Baikady

UK

Member 

2026

Term ends in April 2026

Elected new member

  

2025-2028

 

Elected new member

  

2025-2028

 

Elected new member

  

2025-2028

 

Elected new member

  

2025-2028

 

Elected new member

  

2025-2028

 

 

Consent Management Platform by Real Cookie Banner